drugset / Trial / NCT01173848
Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to examine the effectiveness of vitamin D3 versus vitamin D2 in raising vitamin D levels and suppressing parathyroid hormone levels in patients with kidney disease who are not on dialysis.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-09
- Completion
- 2011-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cholecalciferol | Other / unclassified | 1.25 mg | — |
| Comparator | Ergocalciferol | Small molecule | 1.25 mg | — |